Showing results (1-10 of 563) with videos related to
Sort By:
Pageof 57
Research Communications in Chemical Pathology and Pharmacology|August 1, 1976
The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in miceJ E Lopatka, C N Brewerton, D S Brooks, et al.The New Zealand Medical Journal|March 26, 1980
Bioavailability of two preparations of frusemideD M PatonDrugs of Today (Barcelona, Spain : 1998)|May 12, 2017
Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitisD M PatonDrugs of Today (Barcelona, Spain : 1998)|November 14, 2019
Risankizumab.rzaa: an interleukin monoclonal antibody antagonist binding to the p19 subunit of human IL-23 cytokineD M PatonDrugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's diseaseD M PatonInternational Journal of Clinical Pharmacology Research|January 1, 1986
Comparative bioavailability and half-lives of cloxacillin and flucloxacillinD M PatonDrugs of Today (Barcelona, Spain : 1998)|May 18, 2016
PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemiaD M PatonDrugs of Today (Barcelona, Spain : 1998)|July 5, 2016
Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiencyD M PatonDrugs of Today (Barcelona, Spain : 1998)|April 8, 2017
Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndromeD M PatonDrugs of Today (Barcelona, Spain : 1998)|May 18, 2018
Guselkumab: human monoclonal antibody against interleukin-23 for moderate to severe psoriasisD M PatonPageof 57